The first over-the-counter continuous glucose monitor, Stelo, is now available for use in the United States for up to $99. The FDA cleared Stelo in March for adults aged 18 and older who do not use insulin.
Stelo uses a wearable sensor, paired with an application on the user's smartphone or other smart device to continuously measure blood glucose levels. The device is not for individuals with problematic hypoglycemia or low blood sugar as it is not designed to alert the user about this potentially dangerous condition.
Device manufacturer, Dexcom, said that patients can buy a pack of two sensors for a one-time price of $99 or opt for a monthly subscription for $89.
In June, Abbott Laboratories received the regulator's clearance for two similar devices, Libre Rio and Lingo, for adults with and without diabetes, respectively. Abbott had said it plans to launch Lingo in the U.S. this summer. Lingo has been available in Britain since January for 120-150 pounds ($152-$190) per month.